Background: The generation of velocity-time integrals (VTIs) from Doppler signals is an essential component of standard echocardiographic investigations. The most effective algorithm to compensate for growth in children has, however, not yet been identified. This study was initiated to establish pediatric reference values for VTI and to enhance the interpretability of those values, considering technical and physiological factors.
The quantification of cardiac function is essential for therapeutic decision making in patients with heart disease. Especially in patients with congenital heart disease, who often have abnormal cardiac anatomy, data on the noninvasive measurement of cardiac output (CO) are unsatisfactory.
Cardiac magnetic resonance can involve phase contrast, which is currently regarded as the gold standard to measure flow and CO, but it is not commonly available; moreover, it is rather expensive and time intensive, and it requires sedation or even general anesthesia in young children. [1] [2] [3] [4] [5] In addition, serial or daily measurements to assess therapeutic success during treatment are not practicable using magnetic resonance. For longitudinal monitoring of cardiac function, echocardiography remains the method of choice 6 ; it can be applied easily to all patients at the bedside, but conventionally used two-dimensional (2D) methods lack precision in matters of stroke volume (SV) determination. This becomes apparent when using either biplanar quantification of areas or methods including the integration of Doppler waveforms and the determination of crosssectional areas, because these measurements rely strongly on calculations based on formulas and anatomic assumptions that do not reflect real cardiac anatomy or flow conditions. [6] [7] [8] [9] The measurement of Doppler waveforms across great vessels is carried out by every cardiologist for the estimation of velocities and gradients; this technique is highly reproducible. 10, 11 Furthermore, it has been shown that measurements of the velocity-time integral (VTI) improve CO estimation as it is ''a linear analogue'' of SV, 12 or at least proportional to SV. 13 Nonetheless, interpretation of the area under the Doppler waveform (VTI) is often challenging, because it can be influenced by numerous factors, such as heart rate (HR), the configuration of outflow tracts, and chamber size. This aspect becomes even more complicated if children exhibit differences in cardiac size and HR due to growth. This may imply that high ranges of VTI are defined as ''normal'' despite a potential clinical pathology, which may limit the clinical utility of these reference values.
It was the aim of this study to delineate measures that compensate for these systematic difficulties and to establish reference values for VTI in children that are clinically valuable to distinguish between normal and abnormal SV and CO, without calculating an accurate value for SV or CO.
METHODS

Study Description
Using a prospective approach, children and adolescents were investigated with 2D echocardiography during the period from April 2007 to June 2013. Written informed consent was provided by parents or legal guardians, and the study was approved by the institutional ethics committee (64/2014).
Heart disease was ruled out, and only subjects in sinus rhythm were included. Age, height, and weight were recorded; body surface area (BSA) was calculated using the formula published by Du Bois and Du Bois.
14 A Vivid E9, Vivid 7 (GE Medical Systems, Milwaukee, WI), or iE33 (Philips Medical Systems, Best, the Netherlands) ultrasonic device equipped with standard probes was used. The investigation was performed with the patient in the left supine position to collect standard views according to the guidelines of pediatric echocardiography. 15 Sedation was not needed. For Doppler tracings, only pulsedwave Doppler was used, with the sample volume positioned just distal to the tips of the valve to be investigated. Aortic VTI was taken from an apical five-chamber view; for pulmonary VTI, a short-axis view was used to provide accurate angulations to get the best signal possible and reduce spectral dispersion.
Echocardiographic data sets were recorded digitally, and measurements were performed on a personal computer with EchoPAC version 6.1.2 (GE Medical Systems) or Xcelera release 4.1L1 -4.1.1.1133 (Figures 1-3) . Figure 1 illustrates left ventricular (LV) and right ventricular (RV) length measurement: the basal border of the left ventricle was defined as the line connecting the mitral valve annular hinge points; LV length was measured from the basal border midpoint to the apical endocardium at end-diastole, defined as the frame with the maximal chamber intraluminal area. 15 The basal border of the right ventricle was defined as the line connecting the tricuspid valve annular hinge points; RV length was measured from the basal border midpoint to the RV apex at end-diastole, defined as the frame at which the tricuspid valve closes. 15, 16 The mean VTI was determined by planimetry of three sequential waveforms, as shown in Figures 2 and 3 .
Reference Value Study
On the basis of the results of the pilot study (for more information, see the Appendix, available at www.onlinejase.com), the most suitable parameter on which VTI could be based was defined. Appropriate measurements were carried out in 349 children and adolescents. Reference values were created as percentile curves (Pc) using the LMS method of Cole (LMS version 1.27; Institute of Child Health, London, United Kingdom), which is based on shaping three curves, L, M, and S (L for the box-Cox power, l; M for the mean, m; and S for the coefficient of variation, s), that summarize the measurement's distribution over the range of the covariate and contain the information needed to draw any centile curve.
17,18
Statistical Analysis
Descriptive statistics were assessed using SPSS version 21 (SPSS, Chicago, IL). Normality of distribution was tested using the Kolmogorov-Smirnov test. The Mann-Whitney U test or Student's t test was used to test the significance of the observed differences (P values # .05 were considered to indicate statistical significance). Intra-and interobserver variability were tested as in several previous studies [19] [20] [21] [22] [23] [24] [25] [26] [27] but were nevertheless reevaluated. Echocardiographic data sets of 20 children selected by chance were evaluated twice by the same investigator and additionally by a second investigator, each blinded to the results of the first evaluation. Bland-Altman 28 analysis was used to determine intra-and interobserver variability.
Test of Clinical Utility
To evaluate the clinical utility of the centile curves, patients with known shunt lesions leading to aortic or pulmonary hyperperfusion (group A, patent ductus arteriosus [PDA]; group B, atrial septal defect [ASD]) were examined by the same investigator who performed measurements in healthy children before interventional closure of the PDA or ASD. To categorize the severity of the shunt and following volume overload or chamber enlargement, standard echocardiographic measurements as recommended in current guidelines 15, 29 were carried out. An invasive Qp/Qs measurement was not part of the intervention protocol.
The shunt size of the PDA was assessed quantitatively by measuring the left atrium-to-aortic annulus ratio (LA/Ao) and LV end-diastolic diameter on M-mode imaging. 30 In patients with LA/Ao < 1.5:1, the shunt was considered small or insignificant. LA/Ao between 1.5:1 and 2.0:1 was considered to reflect a moderate shunt size, while LA/Ao > 2:1 was considered to represent large shunts. 31 In patients with ASDs, RV end-diastolic diameters at the basal and midcavity levels were measured in apical four-chamber views for the quantification of RV dilatation, and values were compared with normative data. 16 Additionally, the maximum ASD diameter was measured by transesophageal echocardiography during the intervention.
RESULTS
Feasibility
In total, 349 data sets were analyzed. Data sets were not excluded if measurements for only one ventricle were missing; the inclusion of data set was carried out separately for parameters related to the right and left ventricles. Feasibility was 94.6% for aortic VTI and LV length measurements (n = 330) and 92.8% for pulmonary VTI and RV length measurements (n = 324). Tables 1 and 2 
Reference Values
Statistics
Differences between female and male subjects were statistically significant only for children $7 years of age. Consequently, further analysis was performed in three groups (0-6 years, unisex; 7-20 years, female; 7-20 years, male). Intraobserver variability for echocardiographic measurements was low, with mean differences between 1.2% and 5.1%; interobserver variability was slightly higher, with mean differences between 2.6% and 10.1%. The complete results of the Bland-Altman analysis for intra-and interobserver variability and the correlation coefficients are presented in Table 3 . Table 4 shows the demographic data and echocardiographic values measured in patients with PDA and ASDs. Figures 6 and 7 show the values of children with congenital heart disease plotted into centile curves. The severity of cardiac disease, classified by the comparison of values measured in patients and normal values in the literature, is represented by color codes. Values of patients with PDA with LA/Ao < 1.5:1 are all located in the reference range under the 97th percentile. Values of children with suspected moderate hemodynamic significant ductus arteriosus (LA/Ao 1.5:1-2:1) are mostly in the upper reference range or above the 97th percentile. In contrast, values of children with an allusion to large hemodynamic significant ductus arteriosus and large shunt volume are nearly all outside the reference range ( Figure 6 ). Values from patients with ASDs with normal RV midcavity diameters (Z score < 2) are predominantly located in the reference range, whereas values from children with enlarged right ventricles (RV midcavity enddiastolic diameter Z score > 2) are mainly above the 97th percentile ( Figure 7 ).
Test of Clinical Utility
DISCUSSION
Reference Magnitudes for VTI
To the best of our knowledge, this is the first study describing reference values for VTI to include organ size and HR as measures to incorporate potential influencing factors in the pediatric age group. As this investigation was based on a pilot study to decrease the variability and SD of echocardiographic CO quantification as estimated by VTI Â HR, the results are encouraging. Several studies have questioned the normalization of cardiac structures to BSA or body size, Figure 2 Aortic VTI measurement. Figure 3 Pulmonary VTI measurement.
as it is well known that BSA insufficiently reflects the need for CO, especially in obese individuals 12, 32, 33 or if athletic subjects are examined. 34 Furthermore, cardiac structures apparently do not increase as a linear function of BSA but rather as an exponential function with different exponents for particular dimensions 35 ; hence, other reference measures have to be established for the cardiac structures of children. This is also supported by the findings of a study by Schmitz et al. 36 : whereas morphologic and physiologic conditions remain stable in adults, these conditions undergo permanent changes during upgrowth and should be respected.
Hanseus et al. 24 suggested evaluating VTI in relation to HR because of strong negative correlations that have also been described by other authors. 19, 21, 37, 38 In accordance with this, our study showed a negative correlation, particularly in children <7 years of age. This relationship is likely caused by a predominantly frequency-based regulation of CO and becomes less obvious in larger ventricles that are also able to vary SV using the Frank-Starling mechanism. 39 The product of VTI and HR (VTI Â HR), also called MD, compensates for the fact that VTI values at low HRs will result in comparable CO with those of low VTI values at high HRs.
In addition to HR, a parameter representative of organ size was used to incorporate the individual rate of heart growth. Ventricular length appears suitable, as the measured SD was low, and measurements are easy and reproducible, especially in contrast to LV outflow tract/ RV outflow tract (RVOT) or valve diameter measurements. Eriksen et al. 40 analyzed cardiac function in term and preterm infants and stated consistently that normalization by heart size might be valuable.
The strategy of using centile curves for the measurement of cardiac structures during maturation has become popular for the follow-up of patients for a variety of reasons, in particular because visualization via centile curves permits a quick assessment as to where in the range of normal, above normal, or below normal a data point falls. In addition, centile curves are independent from a uniform distribution of age for the creation of reference values. Age group definition is more or less arbitrary and cannot provide for the individual speed of maturation or cardiac growth, 41 which can be avoided by using the LMS method. 17 Here, we present a reasonable sample size of healthy individuals with a comparable quantity, as sex differences did not become evident in children <7 years of age. This observation has already been confirmed by investigating muscle mass in this age group. 42 Values within the range of the third and 97th percentiles are currently regarded as ''normal''; thus, values less than the third percentile would indicate inadequate flow volume, while values greater than the 97th percentile would be suggestive of hyperperfusion. These centile curves use parameters that express CO but have a distinct dimension. The point is to differentiate between normal and pathologic values, not to determinate exact SV or CO.
Sensitivity of Centile Curves Compared with Other Reference Values
The final possibility for testing the utility of reference values is testing their clinical applicability. Therefore, we investigated patients with known elevated SVs for the right and left ventricles before the interventional closure of a PDA or an ASD.
By comparing the VTI measurements of our patients with PDA with the reference values provided by Pees et al., 19 we were able to demonstrate that a great number of VTI values (28 of 40 = 70%) were located in the reference range of the fifth to the 95th centile curve (consistent with 62 SDs) and would Data are expressed as range (mean 6 SD). Data are expressed as range (mean 6 SD).
consequently be classified as ''normal,'' although there is a known shunt lesion. In contrast, only 13 of 40 values were in the reference range using our method, including some patients with PDA, whose shunt volumes over the PDA were small (LA/Ao < 1.5:1). Increased SV could be more readily detected using our centile curves ( The sensitivity of the centile curves for pulmonary VTI was 75%; factoring in only patients with ASD with enlarged right ventricles (RV midcavity end-diastolic diameter Z score > 2) led to increased sensitivity of 84% (27 of 32 > Pc 97). Unfortunately, these values could not be compared with those of the previously mentioned study, as it did not provide normative data for pulmonary VTI.
Koestenberger et al. 43 reported comparable sensitivity of their reference values, whereby 71% of patients with pulmonary hyperperfusion could be detected among patients with ASDs by measuring the VTI in the RVOT instead of pulmonary VTI. This methodologic discrepancy hampers the comparability of both methods: our patient data could not be evaluated using the reference values from Koestenberger et al. because RVOT VTI is generally lower than pulmonary VTI. 37 The Figure 4 Centile curves for aortic VTI (VTIAo) Â HR. Figure 5 Centile curves for pulmonary VTI (VTIPa) Â HR.
predominant reason for us to create normal values for pulmonary VTI was the fact that recording pulmonary VTI is easier and more standardized than recording RVOT VTI.
Two-Dimensional Echocardiographic CO Estimation: An Obsolete Attempt or an Opportunity for Clinical Decision Making?
At present, numerous technical innovations have diversified cardiologic diagnostics. The evolution of three-dimensional techniques in echocardiography and the development of cardiac magnetic resonance tomography have led to the more precise evaluation of cardiac anatomy and function; however, these techniques are time consuming and not (yet) optimal for daily use. We hold that efforts to advance new techniques as well as the enhancement of established techniques both remain important.
Doppler echocardiographic measurements for CO estimation in children are not widely used. One aspect may be that calculation of SV from VTI is not precise enough.
Additionally, most clinicians are not familiar with the units for VTI Â HR, as they are not included in their clinical protocols and there is only sparse literature about its clinical use, interpretation of values, and reference values. 44 Mohan et al. 45 delineated measurements of VTI Â HR in critically ill children to be a useful tool, and Tibby et al. 44 demonstrated that it can be helpful to detect changes by fluid administration or medication. Both suggest using transesophageal echocardiography, but as transesophageal echocardiography is invasive in children and needs sedation, this is not an option for daily clinical investigations in this patient group.
Goldman et al. 46 provided normal values for stroke distance (VTI) and proposed calculating MD (MD = VTI Â HR) to confirm any suspicion of low-or high-output states. In children, we propose never using VTI alone but calculating MD as well, because it is more robust because of the inverse relationship of VTI and HR and the predominantly frequency-based regulation of CO, especially in young children.
The 2015 guidelines for the use of echocardiography as a monitor for therapeutic interventions in adults advocate VTI measurement as a way to monitor SV and accordingly CO and mention several situations in which serial measurements are mandatory: volume therapy in critically ill patients, during perioperative care, for the administration of inotropic agents, and during the process of weaning patients from LV assist devices. 47 Therefore, if regular CO estimation is required, 2D echocardiography is advantageous over invasive investigation technology or investigation technology with elevated temporal and financial expenditure. In summary, we believe that 2D echocardiographic CO estimation via VTI Â HR measurement and evaluation as a function of length is an opportunity for clinical decision making, and we provide centile curves for the pediatric age group to facilitate differentiation between normal and pathologic values.
Limitations
Our study had some major limitations that deserve further discussion. First, the ''true'' accuracy of our approach evaluating VTI Â HR as a function of ventricular length is unknown and may be inferior to other imaging modalities such as cardiac magnetic resonance tomography, with which SV can be defined accurately. On the other hand, normative data for cardiac magnetic resonance tomographic SV in young children are still lacking, because sedation or anesthesia is needed for their investigation. In addition, the previously mentioned Frank-Starling mechanism may impair the utility of measurements in older children, as SV can vary to a greater extent, independent of HR. As a consequence, the distance between the centile curves increases; this could be misleading for the detection of certain pathologic values, as the range of what is normal has increased. Additionally, the test of clinical utility contains only children aged 0 to 6 years. Consequently, the centile curves for older children and adolescents have not been tested. Furthermore, the clinical utility was tested only for patients with ASDs and PDA; consequently there is no evidence for clinical utility in patients with more complex congenital heart disease. Thus, clinical applicability should be assessed prospectively in the intensive care unit setting to define the utility for guiding therapy with catecholamines, for example.
CONCLUSION
These new reference values for VTI Â HR as a function of ventricular length may be of specific clinical value to improve the assessment of cardiac function, therapeutic decision making, and the follow-up of pediatric patients with heart disease.
APPENDIX: PILOT STUDY
To assess potential influencing factors and to evaluate the most adequate measure to correlate VTI, a complete set of standard parameters for the quantification of chamber size was measured in 50 data sets of children aged 7 to 10 years, assuming that body size and gender differences were small in this group.
METHODS
For LV size assessment, LV end-diastolic length and end-diastolic area were measured in the apical four-chamber view according to the guidelines for the performance of pediatric echocardiography. 15 Enddiastolic diameter was measured on M-mode imaging. The subvalvar LV outflow tract diameter was measured in the parasternal long-axis view during early to midsystole, as well as the aortic valve diameter.
For RV size assessment, RV end-diastolic length and end-diastolic area were measured in the apical four-chamber-view. End-diastolic diameter was measured on M-mode imaging. The subvalvar RVOT diameter and pulmonary valve diameter were measured in the parasternal short-axis view during midsystole.
The mean VTI was determined by planimetry of three sequential waveforms.
RESULTS
Measurements are shown in Supplemental Table 1 . Ventricular length measurements showed low relative SD, as well as the ratio between VTI and ventricular length. Area measurements and measurement of valve or outflow tract diameters showed higher SD. Other decision criteria for ventricular length measurements were the simplicity of measurement, particularly in contrast to valve diameter measurement, and organ size representation.
As an important factor to adapt CO to heightened oxygen demand, HR was selected for VTI evaluation. For example, high VTI values at low HRs might result in a comparable CO with low VTI values at high HRs.
The product of VTI and HR, called MD, compensates for this condition.
Finally, the decision to evaluate VTI multiplied by HR and related to ventricular length was taken.
